Q2 2026 Holdings
Filed 2026-08-14 | 155 holdings | $3.0B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-08-19) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $600.9M | 2,000,000 | 19.9% |
| Peloton Interactive Inc(PTON)Call | CL A COM | 70614W100 | $97.2M | 16,438,900 | 3.2% |
| Herbalife LTD(HLF)Call | COM SHS | G4412G101 | $86.8M | 6,600,000 | 2.9% |
| Viatris Inc(VTRS)Call | COM | 92556V106 | $79.4M | 5,000,000 | 2.6% |
| Bancorp Inc del(TBBK) | COM | 05969A105 | $77.7M | 1,239,887 | 2.6% |
| Edwards Lifesciences Corp(EW)Put | COM | 28176E108 | $72.4M | 800,000 | 2.4% |
| Spdr Series Trust(XBI)Put | ST STR SP BIOT | 78464A870 | $63.3M | 400,000 | 2.1% |
| Bioventus Inc(BVS) | COM CL A | 09075A108 | $56.6M | 6,000,279 | 1.9% |
| Hilton Grand Vacations Inc(HGV)Call | COM | 43283X105 | $56.3M | 1,075,000 | 1.9% |
| Hilton Grand Vacations Inc(HGV) | COM | 43283X105 | $54.1M | 1,033,170 | 1.8% |
| Savara Inc(SVRA) | COM | 805111101 | $43.0M | 6,976,810 | 1.4% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $42.6M | 1,175,951 | 1.4% |
| Amneal Pharmaceuticals Inc(AMRX) | COM STK CL A | 03168L105 | $39.3M | 2,268,751 | 1.3% |
| Evolus Inc(EOLS) | COM | 30052C107 | $38.9M | 5,602,021 | 1.3% |
| ETF SER Solutions(QTUM)Put | DEFIA QUANT ETF | 26922A420 | $36.9M | 223,000 | 1.2% |
| Uniqure NV(QURE)Call | SHS | N90064101 | $36.8M | 800,000 | 1.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $34.4M | 1,862,250 | 1.1% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $34.2M | 1,052,894 | 1.1% |
| Neurocrine Biosciences Inc(NBIX)Call | COM | 64125C109 | $33.7M | 200,000 | 1.1% |
| Praxis Precision Medicines I(PRAX)Put | COM NEW | 74006W207 | $33.5M | 100,000 | 1.1% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $33.3M | 3,383,335 | 1.1% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $31.7M | 5,136,490 | 1.1% |
| Krystal Biotech Inc(KRYS)Put | COM | 501147102 | $31.6M | 85,000 | 1.0% |
| Peloton Interactive Inc(PTON) | CL A COM | 70614W100 | $30.2M | 5,108,995 | 1.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $28.8M | 335,830 | 1.0% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $28.8M | 68,394,000 | 1.0% |
| Jack in the BOX Inc(JACK) | COM | 466367109 | $27.3M | 1,728,659 | 0.9% |
| Gogo Inc(GOGO) | COM | 38046C109 | $27.0M | 8,697,731 | 0.9% |
| Imax Corp(IMAX) | COM | 45245E109 | $26.2M | 658,009 | 0.9% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $25.8M | 1,797,476 | 0.9% |
| Regeneron Pharmaceuticals(REGN)Call | COM | 75886F107 | $24.9M | 40,000 | 0.8% |
| Titan Machy Inc(TITN) | COM | 88830R101 | $23.9M | 1,133,088 | 0.8% |
| RMR Group Inc(RMR) | CL A | 74967R106 | $23.6M | 1,147,902 | 0.8% |
| Fossil Group Inc(FOSL) | COM | 34988V106 | $22.8M | 5,505,128 | 0.8% |
| FOX Factory Hldg Corp(FOXF) | COM | 35138V102 | $22.2M | 1,310,695 | 0.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $22.1M | 820,481 | 0.7% |
| Ridenow Group Inc(RDNW) | COM CL B | 781386305 | $21.8M | 3,272,845 | 0.7% |
| Snap Inc(SNAP)Call | CL A | 83304A106 | $21.3M | 4,800,000 | 0.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $21.0M | 455,660 | 0.7% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $21.0M | 2,951,030 | 0.7% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $20.4M | 1,568,188 | 0.7% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $20.0M | 5,475,040 | 0.7% |
| Benitec Biopharma Inc(BNTC) | COM NEW | 08205P209 | $19.9M | 1,488,371 | 0.7% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $19.8M | 2,359,993 | 0.7% |
| Camping World Hldgs Inc(CWH) | CL A | 13462K109 | $19.5M | 2,551,055 | 0.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $19.0M | 1,901,160 | 0.6% |
| Mimedx Group Inc(MDXG) | COM | 602496101 | $18.4M | 4,767,552 | 0.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $17.8M | 133,759 | 0.6% |
| Usana Health Sciences Inc(USNA) | COM | 90328M107 | $17.3M | 810,074 | 0.6% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $15.8M | 651,993 | 0.5% |